Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 99

1.

Considerations for development of an evidence dossier to support the use of mobile sensor technology for clinical outcome assessments in clinical trials.

Walton MK, Cappelleri JC, Byrom B, Goldsack JC, Eremenco S, Harris D, Potero E, Patel N, Flood E, Daumer M.

Contemp Clin Trials. 2020 Feb 19:105962. doi: 10.1016/j.cct.2020.105962. [Epub ahead of print] Review.

PMID:
32087341
2.

Home Visits for Children With Asthma Reduce Medicaid Costs.

Marshall ET, Guo J, Flood E, Sandel MT, Sadof MD, Zotter JM.

Prev Chronic Dis. 2020 Feb 6;17:E11. doi: 10.5888/pcd17.190288.

3.

A New Function for Perivascular Adipose Tissue (PVAT): Assistance of Arterial Stress Relaxation.

Watts SW, Flood ED, Garver H, Fink GD, Roccabianca S.

Sci Rep. 2020 Feb 4;10(1):1807. doi: 10.1038/s41598-020-58368-x.

4.

Determinants of ion selectivity in ASIC1a- and ASIC2a-containing acid-sensing ion channels.

Lynagh T, Flood E, Boiteux C, Sheikh ZP, Allen TW, Pless SA.

J Gen Physiol. 2020 Feb 3;152(2). pii: e201812297. doi: 10.1085/jgp.201812297.

PMID:
31952079
5.

Patient perspectives on the pathway to psoriatic arthritis diagnosis: results from a web-based survey of patients in the United States.

Ogdie A, Nowell WB, Applegate E, Gavigan K, Venkatachalam S, de la Cruz M, Flood E, Schwartz EJ, Romero B, Hur P.

BMC Rheumatol. 2020 Jan 10;4:2. doi: 10.1186/s41927-019-0102-7. eCollection 2020.

6.

The Parkinson's Disease Activities of Daily Living, Interference, and Dependence Instrument.

Deal LS, Flood E, Myers DE, Devine J, Gray DL.

Mov Disord Clin Pract. 2019 Sep 6;6(8):678-686. doi: 10.1002/mdc3.12833. eCollection 2019 Nov.

PMID:
31745478
7.

Content validity of a novel patient-reported and observer-reported outcomes assessment to evaluate ocular symptoms associated with infectious conjunctivitis in both adult and pediatric populations.

Sarda SP, De La Cruz M, Flood EM, Vanya M, Hwang DG, Ta CN, Narvekar A.

Health Qual Life Outcomes. 2019 Oct 30;17(1):163. doi: 10.1186/s12955-019-1223-9.

8.

Patient preferences for attributes of tyrosine kinase inhibitor treatments for EGFR mutation-positive non-small-cell lung cancer.

Bridges JF, la Cruz M, Pavilack M, Flood E, Janssen EM, Chehab N, Fernandes AW.

Future Oncol. 2019 Dec;15(34):3895-3907. doi: 10.2217/fon-2019-0396. Epub 2019 Oct 17.

PMID:
31621403
9.

Different blood pressure responses in hypertensive rats following chemerin mRNA inhibition in dietary high fat compared to dietary high-salt conditions.

Ferland DJ, Flood ED, Garver H, Yeh ST, Riney S, Mullick AE, Fink GD, Watts SW.

Physiol Genomics. 2019 Nov 1;51(11):553-561. doi: 10.1152/physiolgenomics.00050.2019. Epub 2019 Oct 7.

PMID:
31588871
10.

Healthcare provider perspectives on diagnosing and treating adults with attention-deficit/hyperactivity disorder.

Adler LA, Farahbakhshian S, Romero B, Flood E, Doll H.

Postgrad Med. 2019 Sep;131(7):461-472. doi: 10.1080/00325481.2019.1647080. Epub 2019 Aug 1.

PMID:
31340712
11.

Atomistic Simulations of Membrane Ion Channel Conduction, Gating, and Modulation.

Flood E, Boiteux C, Lev B, Vorobyov I, Allen TW.

Chem Rev. 2019 Jul 10;119(13):7737-7832. doi: 10.1021/acs.chemrev.8b00630. Epub 2019 Jun 27.

PMID:
31246417
12.

Creation of the 5-hydroxytryptamine receptor 7 knockout rat as a tool for cardiovascular research.

Demireva EY, Xie H, Flood ED, Thompson JM, Seitz BM, Watts SW.

Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24.

PMID:
31125290
13.

The evolving role of patient preference studies in health-care decision-making, from clinical drug development to clinical care management.

Jackson Y, Janssen E, Fischer R, Beaverson K, Loftus J, Betteridge K, Rhoten S, Flood E, Lundie M.

Expert Rev Pharmacoecon Outcomes Res. 2019 Aug;19(4):383-396. doi: 10.1080/14737167.2019.1612242. Epub 2019 May 9. Review.

PMID:
31070048
14.

Real-World Patient Experience on the Path to Diagnosis of Ankylosing Spondylitis.

Ogdie A, Benjamin Nowell W, Reynolds R, Gavigan K, Venkatachalam S, de la Cruz M, Flood E, Schwartz EJ, Romero B, Park Y.

Rheumatol Ther. 2019 Jun;6(2):255-267. doi: 10.1007/s40744-019-0153-7. Epub 2019 Apr 30.

15.

AcroVoice: eliciting the patients' perspective on acromegaly disease activity.

Jackson Y, Flood E, Rhoten S, Janssen EM, Lundie M.

Pituitary. 2019 Feb;22(1):62-69. doi: 10.1007/s11102-018-00933-9.

16.

The Potential Role of Individual-Level Benefit-Risk Assessment in Treatment Decision Making: A DIA Study Endpoints Community Workstream.

Reaney M, Bush E, New M, Paty J, Roborel de Climens A, Skovlund SE, Nelsen L, Flood E, Gater A.

Ther Innov Regul Sci. 2019 Sep;53(5):630-638. doi: 10.1177/2168479018807448. Epub 2018 Oct 22.

PMID:
30348019
17.

Selective ion permeation involves complexation with carboxylates and lysine in a model human sodium channel.

Flood E, Boiteux C, Allen TW.

PLoS Comput Biol. 2018 Sep 12;14(9):e1006398. doi: 10.1371/journal.pcbi.1006398. eCollection 2018 Sep.

18.

Perceived Burden of Completion of Patient-Reported Outcome Measures in Clinical Trials:: Results of a Preliminary Study.

Bodart S, Byrom B, Crescioni M, Eremenco S, Flood E.

Ther Innov Regul Sci. 2019 May;53(3):318-323. doi: 10.1177/2168479018788053. Epub 2018 Jul 29.

PMID:
30058368
19.

A Conceptual Model of Angelman Syndrome and Review of Relevant Clinical Outcomes Assessments (COAs).

Grieco JC, Romero B, Flood E, Cabo R, Visootsak J.

Patient. 2019 Feb;12(1):97-112. doi: 10.1007/s40271-018-0323-7.

20.

Comparison of permeation mechanisms in sodium-selective ion channels.

Boiteux C, Flood E, Allen TW.

Neurosci Lett. 2019 May 1;700:3-8. doi: 10.1016/j.neulet.2018.05.036. Epub 2018 May 26. Review.

PMID:
29807068

Supplemental Content

Loading ...
Support Center